Ticker
HRTXCompany Name
HERON THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Depreciation, Amortization & Accretion | Earning Before Interest & Taxes (EBIT) | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) |
---|---|---|---|
6/30/2025 | $ 2.32M | $ 1.55M | $ 3.88M |
3/31/2025 | $ 2.35M | $ -5.3M | $ -2.95M |
12/31/2024 | $ 2.49M | $ -11.1M | $ -8.61M |
9/30/2024 | $ 2.63M | $ -27.46M | $ -24.84M |
6/30/2024 | $ 2.77M | $ -47.62M | $ -44.85M |
3/31/2024 | $ 2.87M | $ -80.45M | $ -77.58M |
12/31/2023 | $ 2.9M | $ -110.06M | $ -107.16M |
9/30/2023 | $ 2.98M | $ -118.87M | $ -115.89M |
6/30/2023 | $ 2.95M | $ -135.77M | $ -132.81M |
3/31/2023 | $ 2.89M | $ -150.07M | $ -147.18M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT + DepAmor
(=) EBITDA
EBITDA for HERON THERAPEUTICS INC is calculated as follows: EBIT [ $ -228.7M ] + DepAmor [ $ 2.7M ]
(=) EBITDA [ $ -226M ]
Minimum
Jun 30, 2021
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.25K |
---|---|
min | $ -493.3M |
max | $ 590.6M |
average | $ 58.79M |
median | $ 8.83M |
std | $ 166.94M |